Granulocyte colony stimulating factor/macrophage colony stimulating factor improves postinfarct ventricular function

Takayuki Miki1, Tetsuji Miura, Yasuhiro Nishino

  • 1Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan. tmiki@sapmed.ac.jp

Insights

Granulocyte colony stimulating factor (G-CSF) and macrophage colony stimulating factor (M-CSF) treatment improved ventricular function after myocardial infarction (MI) by enhancing infarct repair and reducing adverse remodeling.

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Myocardial infarction (MI) leads to ventricular dysfunction and adverse remodeling.
  • Mobilization of bone marrow cells is a potential therapeutic strategy for cardiac repair.

Purpose of the Study:

  • To investigate the effects of G-CSF and M-CSF on ventricular function post-MI.
  • To assess the impact of CSF treatment on infarct repair and cardiac remodeling.

Main Methods:

  • Rats underwent MI and received either vehicle or G-CSF/M-CSF treatment.
  • Ventricular function was assessed via isolated heart perfusion.
  • Histological and molecular analyses identified cell proliferation, collagen organization, and gene expression.

Main Results:

  • CSF treatment increased bone marrow-derived cells in the infarct border zone.
  • While not reducing infarct size, CSF treatment improved left ventricular developed pressure.
  • Functional improvement correlated with suppressed infarct expansion and more organized collagen fibers.

Conclusions:

  • G-CSF/M-CSF treatment enhances ventricular contractile function after MI.
  • This improvement is likely due to accelerated infarct repair and suppressed border zone remodeling.
  • M-CSF alone may contribute to the observed functional benefits.